instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'MYCOPHENOLATE MOFETIL'? | Encapsulating Peritoneal Sclerosis Presenting after Two Donor Kidney Transplantations: A Case Report and Literature Review.
Encapsulating peritoneal sclerosis is a rare, recurring complication in peritoneal dialysis (PD) patients. With a mortality rate of 51%, it continues to be a therapeutic enigma among clinicians. H... | Oral | DrugAdministrationRoute | CC BY-NC | 34414212 | 20,135,174 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Encapsulating Peritoneal Sclerosis Presenting after Two Donor Kidney Transplantations: A Case Report and Literature Review.
Encapsulating peritoneal sclerosis is a rare, recurring complication in peritoneal dialysis (PD) patients. With a mortality rate of 51%, it continues to be a therapeutic enigma among clinicians. H... | Oral | DrugAdministrationRoute | CC BY-NC | 34414212 | 20,135,174 | 2021 |
What was the administration route of drug 'TACROLIMUS'? | Encapsulating Peritoneal Sclerosis Presenting after Two Donor Kidney Transplantations: A Case Report and Literature Review.
Encapsulating peritoneal sclerosis is a rare, recurring complication in peritoneal dialysis (PD) patients. With a mortality rate of 51%, it continues to be a therapeutic enigma among clinicians. H... | Oral | DrugAdministrationRoute | CC BY-NC | 34414212 | 20,135,174 | 2021 |
What was the administration route of drug 'TAMOXIFEN'? | Encapsulating Peritoneal Sclerosis Presenting after Two Donor Kidney Transplantations: A Case Report and Literature Review.
Encapsulating peritoneal sclerosis is a rare, recurring complication in peritoneal dialysis (PD) patients. With a mortality rate of 51%, it continues to be a therapeutic enigma among clinicians. H... | Oral | DrugAdministrationRoute | CC BY-NC | 34414212 | 20,135,174 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoalbuminaemia'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrotic syndrome'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal-limited thrombotic microangiopathy'. | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | NINTEDANIB | DrugsGivenReaction | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Decreased appetite'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovered | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Diarrhoea'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovered | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Hepatic enzyme increased'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovered | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Hypertension'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovering | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Hypoalbuminaemia'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovering | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Nephrotic syndrome'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovered | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Proteinuria'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Recovering | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
What was the outcome of reaction 'Renal impairment'? | Nintedanib-Induced Renal Thrombotic Microangiopathy.
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with ... | Not recovered | ReactionOutcome | CC BY-NC | 34414215 | 19,741,075 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amegakaryocytic thrombocytopenia'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | ROMIPLOSTIM | DrugsGivenReaction | CC BY-NC | 34414253 | 19,856,682 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | ROMIPLOSTIM | DrugsGivenReaction | CC BY-NC | 34414253 | 19,856,682 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Floppy infant'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gene mutation'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | ROMIPLOSTIM | DrugsGivenReaction | CC BY-NC | 34414253 | 19,856,682 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,946,511 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal respiratory distress syndrome'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | ROMIPLOSTIM | DrugsGivenReaction | CC BY-NC | 34414253 | 19,856,682 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oligohydramnios'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,130 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature labour'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,946,511 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature rupture of membranes'. | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34414253 | 19,941,130 | 2021 |
What is the weight of the patient? | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | .5 kg. | Weight | CC BY-NC | 34414253 | 19,997,448 | 2021 |
What was the administration route of drug 'LEVOTHYROXINE SODIUM'? | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34414253 | 19,941,414 | 2021 |
What was the administration route of drug 'METFORMIN HYDROCHLORIDE'? | An Unusual Case of Severe Persistent Neonatal Thrombocytopenia in an Extremely Low Birth Weight, Extreme Preterm Neonate.
Neonatal thrombocytopenia is a common hematological problem but refractory thrombocytopenia is very rare in neonates. A systematic and diligent workup will result in arriving at the proper diagnosis... | Transplacental | DrugAdministrationRoute | CC BY-NC | 34414253 | 19,941,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alopecia'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'BK polyomavirus test positive'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiorenal syndrome'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cognitive disorder'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Costochondritis'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cough'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus colitis'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus test positive'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus test positive'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised oedema'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retroperitoneal haemorrhage'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin disorder'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transplant dysfunction'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34414665 | 20,175,397 | 2021-12 |
What was the outcome of reaction 'Sepsis'? | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study.
Although most patients recover within several weeks after acute COVID-19, some of them develop long-lasting clinical symptoms. Renal transplant recipients have an increased mortality risk from COVID-19. We aimed to d... | Fatal | ReactionOutcome | CC BY | 34414665 | 20,175,397 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour haemorrhage'. | Rare Distal Metastasis of Endometrial Adenocarcinoma Impersonating as Primary Colon Cancer.
An 89-year-old Caucasian female with a recent diagnosis of endometrial adenocarcinoma status post hysterectomy and acute deep vein thrombosis on anticoagulation presented with hematochezia. Colonoscopy revealed sigmoid colon str... | APIXABAN | DrugsGivenReaction | CC BY-NC | 34414815 | 19,963,499 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema multiforme'. | Moxifloxacin-induced oral erythema multiforme: An unusual adverse effect hitherto unreported.
Moxifloxacin is a fluoroquinolone with excellent activity in community-acquired respiratory tract infections. Common adverse effects are gastrointestinal symptoms, headache, dizziness, etc., Some serious adverse effects includ... | MOXIFLOXACIN | DrugsGivenReaction | CC BY-NC-SA | 34414908 | 19,924,568 | 2021 |
What was the outcome of reaction 'Erythema multiforme'? | Moxifloxacin-induced oral erythema multiforme: An unusual adverse effect hitherto unreported.
Moxifloxacin is a fluoroquinolone with excellent activity in community-acquired respiratory tract infections. Common adverse effects are gastrointestinal symptoms, headache, dizziness, etc., Some serious adverse effects includ... | Recovered | ReactionOutcome | CC BY-NC-SA | 34414908 | 19,924,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary hypertension'. | Pulmonary hypertension in patients with chronic myeloid leukemia.
Dasatinib, a tyrosine kinase inhibitor (TKI), induces pulmonary hypertension (PH) in patients with chronic myeloid leukemia (CML). However, information on other TKIs is limited.We retrospectively analyzed PH prevalence by reviewing transthoracic echocard... | IMATINIB MESYLATE | DrugsGivenReaction | CC BY-NC | 34414970 | 19,969,492 | 2021-08-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tricuspid valve incompetence'. | Pulmonary hypertension in patients with chronic myeloid leukemia.
Dasatinib, a tyrosine kinase inhibitor (TKI), induces pulmonary hypertension (PH) in patients with chronic myeloid leukemia (CML). However, information on other TKIs is limited.We retrospectively analyzed PH prevalence by reviewing transthoracic echocard... | IMATINIB MESYLATE | DrugsGivenReaction | CC BY-NC | 34414970 | 19,969,492 | 2021-08-20 |
What was the outcome of reaction 'Pulmonary hypertension'? | Pulmonary hypertension in patients with chronic myeloid leukemia.
Dasatinib, a tyrosine kinase inhibitor (TKI), induces pulmonary hypertension (PH) in patients with chronic myeloid leukemia (CML). However, information on other TKIs is limited.We retrospectively analyzed PH prevalence by reviewing transthoracic echocard... | Recovered | ReactionOutcome | CC BY-NC | 34414970 | 19,969,492 | 2021-08-20 |
What was the outcome of reaction 'Tricuspid valve incompetence'? | Pulmonary hypertension in patients with chronic myeloid leukemia.
Dasatinib, a tyrosine kinase inhibitor (TKI), induces pulmonary hypertension (PH) in patients with chronic myeloid leukemia (CML). However, information on other TKIs is limited.We retrospectively analyzed PH prevalence by reviewing transthoracic echocard... | Recovered | ReactionOutcome | CC BY-NC | 34414970 | 19,969,492 | 2021-08-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemothorax'. | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | CETRORELIX, CHORIOGONADOTROPIN ALFA, DEXAMETHASONE, DIPYRONE, FENTANYL, FOLLITROPIN ALFA, KETOPROFEN, MENOTROPINS, ONDANSETRON, PROPOFOL, TRIPTORELIN ACETATE | DrugsGivenReaction | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
What was the dosage of drug 'CETRORELIX'? | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | 0.25 MG, DAILY | DrugDosageText | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
What was the dosage of drug 'CHORIOGONADOTROPIN ALFA'? | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | 250 UG, ONCE/SINGLE | DrugDosageText | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
What was the dosage of drug 'FOLLITROPIN ALFA'? | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | 225 IU, DAILY | DrugDosageText | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
What was the dosage of drug 'MENOTROPINS'? | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | 75 IU, DAILY | DrugDosageText | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
What was the dosage of drug 'TRIPTORELIN ACETATE'? | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | 0.2 MG, ONCE/SINGLE | DrugDosageText | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
What was the outcome of reaction 'Haemothorax'? | Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report.
Spontaneous hemothorax is a rare disorder characterized by pleural fluid hematocrit greater than 50% of the peripheral blood hematocrit without natural or iatrogenic trauma to the lungs or pleural space. Since the first case of CO... | Recovered | ReactionOutcome | CC BY | 34415132 | 20,237,475 | 2021-10-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.
This report describes the case of a female kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and post... | AZATHIOPRINE, CYCLOSPORINE, LEVOTHYROXINE, MYCOPHENOLATE MOFETIL, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34415135 | 20,719,066 | 2021-10-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure via breast milk'. | Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.
This report describes the case of a female kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and post... | AZATHIOPRINE, CYCLOSPORINE, LEVOTHYROXINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34415135 | 20,287,525 | 2021-10-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.
This report describes the case of a female kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and post... | AZATHIOPRINE, CYCLOSPORINE, LEVOTHYROXINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34415135 | 20,287,525 | 2021-10-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.
This report describes the case of a female kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and post... | AZATHIOPRINE, CYCLOSPORINE, LEVOTHYROXINE, MYCOPHENOLATE MOFETIL, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34415135 | 20,719,066 | 2021-10-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.
This report describes the case of a female kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and post... | AZATHIOPRINE, CYCLOSPORINE, LEVOTHYROXINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34415135 | 20,287,525 | 2021-10-04 |
What is the weight of the patient? | Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism.
This report describes the case of a female kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and post... | 2.23 kg. | Weight | CC BY | 34415135 | 20,287,525 | 2021-10-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34416869 | 19,785,704 | 2021-08-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34416869 | 19,785,704 | 2021-08-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34416869 | 19,788,545 | 2021-08-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34416869 | 19,785,704 | 2021-08-20 |
What was the administration route of drug 'TEMOZOLOMIDE'? | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | Oral | DrugAdministrationRoute | CC BY | 34416869 | 19,785,704 | 2021-08-20 |
What was the outcome of reaction 'Drug intolerance'? | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | Recovered | ReactionOutcome | CC BY | 34416869 | 19,788,545 | 2021-08-20 |
What was the outcome of reaction 'Toxicity to various agents'? | Primary neuroendocrine tumor of the pineal gland: a case report.
BACKGROUND
Primary intracranial neuroendocrine tumors are exceedingly rare, with few cases in the literature. We present a case of a primary neuroendocrine carcinoma of the pineal gland, which is the second that has ever been reported.
METHODS
A 53-year... | Recovered | ReactionOutcome | CC BY | 34416869 | 19,788,545 | 2021-08-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infective aneurysm'. | Pseudoaneurysm of the ascending aorta: case report of a donor-derived Pseudomonas infection in a heart transplant recipient.
BACKGROUND
Mycotic aortic pseudoaneurysm is a rare complication after heart transplantation (HTX) with remarkable mortality. Intrathoracic infection is a well-documented predisposing factor for t... | METHYLPREDNISOLONE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34418979 | 20,597,794 | 2021-08-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pseudoaneurysm of the ascending aorta: case report of a donor-derived Pseudomonas infection in a heart transplant recipient.
BACKGROUND
Mycotic aortic pseudoaneurysm is a rare complication after heart transplantation (HTX) with remarkable mortality. Intrathoracic infection is a well-documented predisposing factor for t... | METHYLPREDNISOLONE, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34418979 | 20,597,794 | 2021-08-21 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.